¼¼°èÀÇ ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
Reporter Gene Assay Market with COVID-19 Impact Analysis, By Product Type, By Application, By Usage, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1335305
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 311 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,475,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,403,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,781,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå ±Ô¸ð´Â 2022³â 52¾ï 830¸¸ ´Þ·¯·Î 2023³âºÎÅÍ 2030³â±îÁö CAGR 10.6%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - ½ÃÀå ¿ªÇÐ

¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁö´Ï½º¸¦ °¡Á®¿À´Â ±¹°¡¿¡ µû¶ó ´õ ¼¼ºÐÈ­µË´Ï´Ù.

¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - °æÀï »óȲ

¼±Áø±¹°ú ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ CROÀÇ Á¸Àç·Î ÀÎÇØ ½ÃÀå °æÀïÀÌ Ä¡¿­ÇÕ´Ï´Ù. ¶ÇÇÑ, CRO´Â Ç¥Àû ¾à¹° °³¹ßÀ» À§ÇØ ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌÀ» µµÀÔÇÏ¿© È÷Æ® È­ÇÕ¹°À» ½Äº°Çϰí È÷Æ®-Åõ-¸®µå¸¦ ¼öÇàÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ÁøÀÔ ±â¾÷°ú Á¤ºÎ´Â Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃëÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀº M&A, R&D Ȱµ¿, Á¦ÈÞ, Çõ½Å Á¦Ç° Ãâ½Ã, °øµ¿ ¿¬±¸ µîÀÇ Àü·«À» ÆîÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Taysha Gene Therapies´Â 2021³â 1¿ù ¹Ì±¹ ³ë½ºÄ³·Ñ¶óÀ̳ªÁÖ ´õ·³¿¡ À¯ÀüÀÚ Ä¡·áÁ¦ Á¦Á¶ ½Ã¼³À» ½Å¼³ÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ¾÷°è Á¶»ç

Á¦5Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå »óȲ

Á¦7Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦8Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - ¿ëµµº°

Á¦9Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - ¿ëµµº°

Á¦10Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

Á¦11Àå ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¸®Æ÷ÅÍ À¯ÀüÀÚ ¾î¼¼ÀÌ ¾÷°è

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Reporter gene assay market size was valued at USD 5,208.3 Million in 2022, expanding at a CAGR of 10.6% from 2023 to 2030.

Reporter gene assays are the most widely used cell-based assays for determining the biological role of target molecules. As a result, in living cells, researchers prefer fluorescence assays for real-time analysis of dynamic processes. This is possible owing to the availability of numerous colored reporter gene modifications, along with the fact that cell lysis or the addition of any kind of substrate is not needed for quantification. Moreover, a reporter gene is a gene type that researchers attributed to the regulatory sequence of another essential gene in cell cultures, animals, microbes, and plants.

Reporter Gene Assay Market- Market Dynamics:

Reporter Gene Assay Market- Key Insights:

Reporter Gene Assay Market- Segmentation Analysis:

Reporter Gene Assay Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Reporter Gene Assay Market- Competitive Landscape:

The market competition is high due to the CROs' presence in developed and developing markets. Moreover, for targeted drug discovery CROs also incorporate reporter gene assays to perform hit identification and hit-to-lead. Furthermore, market participants and governments have undertaken strategies initiatives this is expected to fuel market growth. Key players are deploying several strategies such as merger & acquisition, R&D activities, partnership, innovative product launches, and collaboration. For instance, in January 2021, Taysha Gene Therapies announced to build off a new current Good Manufacturing Practices (cGMP) gene therapy manufacturing facility in Durham, North Carolina, US to support preclinical, clinical, and commercial cGMP production of its broad gene therapy pipeline drugs.

Recent Developments:

For instance, in November 2021, Asuragen, Inc. released a new kit to find pathogenic variants in the CFTR gene. Additionally, the AmplideX® PCR/CE CFTR Kit, intended for research use only, offers broader coverage of the diverse U.S. population1,2 than any other commercially available, targeted CFTR testing assay.

Key features of the study:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL REPORTER GENE ASSAY MARKET KEY PLAYERS

GLOBALREPORTER GENE ASSAY MARKET, BY PRODUCT TYPE

GLOBAL REPORTER GENE ASSAY MARKET, BY APPLICATION

GLOBAL REPORTER GENE ASSAY MARKET, BY USAGE

GLOBAL REPORTER GENE ASSAY MARKET, BY END-USE

GLOBAL REPORTER GENE ASSAY MARKET, BY REGION

Table of Contents

1. Reporter Gene Assay Market Overview

2. Executive Summary

3. Reporter Gene Assay Key Market Trends

4. Reporter Gene Assay Industry Study

5. Reporter Gene Assay Market: COVID-19 Impact Analysis

6. Reporter Gene Assay Market Landscape

7. Reporter Gene Assay Market - By Product Type

8. Reporter Gene Assay Market - By Application

9. Reporter Gene Assay Market - By Usage

10. Reporter Gene Assay Market - By End-use

11. Reporter Gene Assay Market- By Geography

12. Key Vendor Analysis- Reporter Gene Assay Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â